arrow
L

Leona Osawa

University of Yamanashi
H指数:16
被引数:784

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Significance of Measuring Interferon-γ-Induced Protein-10 Levels in Patients Receiving Systemic Therapies for Unresectable Hepatocellular Carcinoma

测量干扰素-γ诱导蛋白-10水平在不适合手术切除的肝癌患者接受全身治疗中的意义

2026-01-010
PRE
Risk Factors for the Exacerbation of Esophageal Varices in Patients Receiving Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma

不可切除性肝细胞癌患者接受阿替利珠单抗联合贝伐珠单抗治疗时食管静脉曲张恶化的危险因素

2025-09-010
PRE
Evaluation of weight loss and improvement of steatotic liver disease using magnetic resonance imaging in patients with metabolic dysfunction associated steatotic liver disease

磁共振成像评价代谢功能障碍相关脂肪性肝病患者体重减轻和脂肪性肝病改善情况

2025-01-210
OA
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease
2023-03-056
OAAI
Significance of serum IP-10/CXCL10 measurement in predicting post-direct acting antiviral treatment liver function in patients with HCV-decompensated liver cirrhosis
2022-12-134
PRE
Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencing
2022-03-315
OAAI
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease

肝纤维化和脂肪肝是心血管疾病的独立危险因素

2021-07-0847
PREAI
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients

乙型肝炎核心相关抗原预测乙型肝炎e抗原阴性慢性乙型肝炎患者的疾病进展和肝细胞癌

2021-06-1615
PREAI
Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis C
2020-09-289
PREAI
Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis
2020-09-2627
PREAI